Avid Bioservices Revenue and Competitors

Location

$125M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Avid Bioservices's estimated annual revenue is currently $80.9M per year.(i)
  • Avid Bioservices's estimated revenue per employee is $217,000
  • Avid Bioservices's total funding is $125M.

Employee Data

  • Avid Bioservices has 373 Employees.(i)
  • Avid Bioservices grew their employee count by 27% last year.

Avid Bioservices's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
CEOReveal Email/Phone
3
VP, PeopleReveal Email/Phone
4
VP OperationsReveal Email/Phone
5
VP, General Counsel & Corporate SecretaryReveal Email/Phone
6
VP, QualityReveal Email/Phone
7
VP, Process Development Viral Vector TechnologiesReveal Email/Phone
8
VP, Process DevelopmentReveal Email/Phone
9
VP Supply Chain OperationsReveal Email/Phone
10
VP in charge Process Development and MS&TReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Avid Bioservices?

Avid Bioservices was established to provide highly specialized cell culture and process development through cGMP manufacturing services for the biotechnology and biopharmaceutical industries utilizing mammalian cell culture to support pre-clinical, Phase I, II, III and commercial production. We can provide a complete package from process development through full-scale manufacturing, purification and bulk packaging. Our capabilities include a full range of analytical services and regulatory support. Customers may request a complete program starting with process development through bulk packaging of their product or develop customized programs based on your requirements.

keywords:N/A

$125M

Total Funding

373

Number of Employees

$80.9M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Avid Bioservices News

2022-04-17 - Should You Buy Avid Bioservices Inc (CDMO) Stock After it Is Down 4.75% in a Week?

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of...

2022-04-17 - Comparing Avid Bioservices (NASDAQ:CDMO) & Teva ...

Comparing Avid Bioservices (NASDAQ:CDMO) & Teva Pharmaceutical Industries (NYSE:TEVA). Posted by admin on Apr 19th, 2022.

2022-04-13 - Avid Bioservices, Inc. (NASDAQ:CDMO) CEO Sells $54547.84 ...

Avid Bioservices, Inc, a contract development and manufacturing organization, provides process development and current good manufacturing...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$106.3M373-2%N/A
#2
$80.6M4305%N/A
#3
$84.6M4512%N/A
#4
$91M502116%N/A
#5
$92.6M511-15%N/A